Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Comparing walking with powered and passive prosthetic knees for amputees

Official title: Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss

Run by Loma Linda University · NCT05831696 · Data updated 2026-11-12

This study tests whether walking with a powered prosthetic knee is easier and more efficient for people with leg amputations compared to using a standard knee.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment12 (estimated)
SponsorLoma Linda University
Academic / other
Locations1 site (Loma Linda, California)
StatusRecruiting
StartedFebruary 27, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedFebruary 4, 2026
Trial IDNCT05831696 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-75 with unilateral transfemoral amputation who have experience using a prosthesis and demonstrate a high level of ambulation potential.

Probably not a fit

Patients who have multiple amputations, those who cannot walk at different speeds, or who are less than 180 days post-amputation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the metabolic costs associated with walking using a powered microprocessor-controlled knee compared to a standard prosthesis among individuals with transfemoral amputation. Participants will undergo a series of treadmill tests to measure heart rate and metabolic function while using both types of prosthetic knees. The study aims to determine if the powered knee improves walking efficiency in various conditions, including level ground and inclines. Participants will be fitted with a metabolic analyzer and heart rate monitor to collect data during the tests.

Why it matters

Potential benefit: If successful, this study could lead to improved walking efficiency and quality of life for amputees using powered prosthetic knees.

How similar studies have gone: Previous studies have shown promising results with powered prosthetic devices, indicating potential benefits in mobility and metabolic efficiency.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males and Females with unilateral knee disarticulation or transfemoral (KD/TF) amputation.
* a body mass greater than 49Kg and less than 117Kg
* 18-75 years of age
* Have an ambulation potential of K3 or K4
* Use a prosthesis daily for walking or sports activities
* No less than six months of experience with a prosthesis
* No socket issues or changes in the last six weeks
* No residual limb pain affecting functional ability.

Exclusion Criteria:

* Cannot walk at different speeds (MCFL K0-K2)
* Limb-loss below the knee or through the hip
* More than one amputation.
* Uses an assistive device for walking
* Uncontrolled edema in leg compartments
* Compromised skin of the residual limb or contralateral foot
* Are 180 days or less post-amputation
* Pregnant (self-reported)

Where it's running

  • Loma Linda University
    Loma Linda, California, United States
    Recruiting

Study contacts

  • Principal investigator: Michael Davidson, Ph.D. — Loma Linda University Health
  • Study coordinator: Michael Davidson, Ph.D.
  • Email: mdavidson@llu.edu
  • Phone: 9095586516

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.